Aslan Pharmaceuticals Stock Forecast - Rate Of Daily Change
| ASLNDelisted Stock | USD 0.60 0.03 4.76% |
Aslan Stock Forecast is based on your current time horizon.
Aslan |
| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 1.32 | 0.95 |
| Check Aslan Pharmaceuticals Volatility | Backtest Aslan Pharmaceuticals | Trend Details |
Aslan Pharmaceuticals Trading Date Momentum
| On November 30 2024 Aslan Pharmaceuticals was traded for 0.60 at the closing time. The top price for the day was 0.70 and the lowest listed price was 0.60 . There was no trading activity during the period 0.0. Lack of trading volume on November 30, 2024 did not affect price variability. The overall trading delta against the current closing price is 5.00% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare Aslan Pharmaceuticals to competition
View Aslan Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Aslan Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Aslan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aslan Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aslan Pharmaceuticals stock market strength indicators, traders can identify Aslan Pharmaceuticals entry and exit signals to maximize returns.
Aslan Pharmaceuticals Risk Indicators
The analysis of Aslan Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aslan Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aslan stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.79 | |||
| Standard Deviation | 9.4 | |||
| Variance | 88.32 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Aslan Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aslan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aslan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Aslan Stock
| 0.75 | BKRKY | Bank Rakyat | PairCorr |
| 0.69 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.75 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.69 | PPERF | Bank Mandiri Persero | PairCorr |
Moving against Aslan Stock
| 0.86 | DIS | Walt Disney Sell-off Trend | PairCorr |
| 0.85 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.81 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.79 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.76 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Aslan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aslan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aslan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aslan Pharmaceuticals to buy it.
The correlation of Aslan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aslan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aslan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aslan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |